top of page

Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745

  • pharmaserviceinc
  • Apr 27, 2022
  • 1 min read

Check the final guidance from the MDCG. This document provides further explanations and examples clarifying these provisions in order to support the uniform application of the MDR across the EU. The document starts with the general discussion of the borderline between medical devices and medicinal products, including relevant definitions and examples. Separate chapters are dedicated to herbal products, substance-based devices and medical device and medicinal product combinations.


Find it attached!





 
 
 

Comments


  • LinkedIn

©2021 por AF Pharma Service Europe. Creada con Wix.com

bottom of page